After Surging 918%, Is Micron Stock Still a Buy? Here's What History Says.

Micron’s stock has surged 918% over the past 12 months and remains presented as a value opportunity, trading at 50x trailing earnings but just 10x forward P/E. Q2 2026 revenue jumped 195% year over year to $23.9 billion, and Q3 guidance calls for $33.5 billion in revenue, 81% gross margin, and $18.90 EPS. The article also notes Micron has sold out HBM chips for 2026 and was named a supplier for Nvidia’s Vera Rubin AI architecture.

Analysis

MU is functioning less like a cyclical memory name and more like a near-term capacity monopoly in a constrained AI supply chain. The second-order effect is that HBM scarcity is no longer just supporting pricing; it is forcing hyperscalers and accelerator vendors to pre-commit demand, which should keep contract terms seller-favorable for multiple quarters even if end-demand wobbles. That makes the earnings path unusually visible relative to the rest of semis, but it also concentrates risk: any sign of 2027 supply normalization or customer qualification delays would hit the multiple faster than the earnings line.

The market is likely underestimating how much MU’s strength can bleed into NVDA while pressuring AVGO’s relative positioning. NVDA benefits from having a confirmed memory ecosystem behind its next platform, reducing execution risk for Rubin and making the roadmap more financeable for cloud customers. By contrast, AVGO’s reaction suggests investors are starting to separate “AI beneficiary” from “AI priced for perfection”; that should continue to favor names with direct unit bottlenecks and visible backlog over diversified infrastructure stories.

The contrarian read is that this is not a cheap stock in the classic sense, it is a cheap stock on peak-margin assumptions. A forward P/E around 10 is only compelling if the market believes the current pricing regime persists long enough to de-lever fixed costs and fund capacity without triggering oversupply; if margin normalizes even modestly, the multiple can re-rate against a lower earnings base. The next catalyst window is the next 1-2 earnings prints: guidance quality matters more than the quarter itself, because the stock is now trading on the durability of HBM tightness, not just the existence of it.

Key Decisions for Investors

• Long MU on a 1-3 month horizon on any pullback toward post-earnings support; risk/reward favors owning a capacity-constrained supplier with backlog visibility, but trim if management stops raising near-term gross margin targets.
• Pair trade: long MU / short AVGO for 4-8 weeks to isolate the market’s preference for pure-play AI bottlenecks over diversified AI exposure; use AVGO as the funding leg if valuation dispersion widens further.
• Add NVDA on confirmation that Rubin supply is de-risked by HBM commitments; this is a second-order beneficiary trade with lower upside than MU but better durability if AI capex stays elevated into 2027.
• Use MU call spreads rather than outright longs if implied volatility is elevated; structure for the next earnings cycle with upside tied to another guide raise, while capping downside if the market rotates away from AI beta.
• Avoid chasing the move after a 12% one-day flush unless the stock holds its prior breakout level for several sessions; the key risk is not demand collapse but a multiple reset if investors start discounting peak margin.